Impact of hospital antibiotic use on patient-level risk of death among 36,124,372 acute and medical admissions in England

<p><strong>Objectives:</strong> Initiatives to curb hospital antibiotic use might be associated with harm from undertreatment. We examined the extent to which variation in hospital antibiotic prescribing is associated with mortality risk in acute/general medicine inpatients.</p&...

Full description

Bibliographic Details
Main Authors: Budgell, E, Davies, T, Donker, T, Hopkins, S, Wyllie, D, Peto, T, Gill, M, Llewelyn, M, Walker, AS
Format: Journal article
Language:English
Published: Elsevier 2021
_version_ 1797109060894457856
author Budgell, E
Davies, T
Donker, T
Hopkins, S
Wyllie, D
Peto, T
Gill, M
Llewelyn, M
Walker, AS
author_facet Budgell, E
Davies, T
Donker, T
Hopkins, S
Wyllie, D
Peto, T
Gill, M
Llewelyn, M
Walker, AS
author_sort Budgell, E
collection OXFORD
description <p><strong>Objectives:</strong> Initiatives to curb hospital antibiotic use might be associated with harm from undertreatment. We examined the extent to which variation in hospital antibiotic prescribing is associated with mortality risk in acute/general medicine inpatients.</p> <p><strong>Methods:</strong> This ecological analysis examined Hospital Episode Statistics from 36,124,372 acute/general medicine admissions (≥16y) to 135 acute hospitals in England, 01/April/2010–31/March/2017. Random-effects meta-regression was used to investigate whether heterogeneity in adjusted 30-day mortality was associated with hospital-level antibiotic use, measured in defined-daily-doses (DDD)/1,000 bed-days. Models also considered DDDs/1,000 admissions and DDDs for narrow-spectrum/broad-spectrum antibiotics, parenteral/oral, and local interpretations of World Health Organization Access, Watch, and Reserve antibiotics.</p> <p><strong>Results:</strong> Hospital-level antibiotic DDDs/1,000 beddays varied 15-fold with comparable variation in broad-spectrum, parenteral, and Reserve antibiotic use. After extensive adjusting for hospital case-mix, the probability of 30-day mortality changed -0.010% (95% CI: -0.064,+0.044) for each increase of 500 hospital-level antibiotic DDDs/1,000 bed-days. Analyses of other metrics of antibiotic use showed no consistent association with mortality risk.</p> <p><strong>Conclusions:</strong> We found no evidence that wide variation in hospital antibiotic use is associated with adjusted mortality risk in acute/general medicine inpatients. Using low-prescribing hospitals as benchmarks could help drive safe and substantial reductions in antibiotic consumption of up-to one-third in this population.</p>
first_indexed 2024-03-07T07:36:46Z
format Journal article
id oxford-uuid:a40b78a2-cf52-48ee-a9d2-11cf1b5636fb
institution University of Oxford
language English
last_indexed 2024-03-07T07:36:46Z
publishDate 2021
publisher Elsevier
record_format dspace
spelling oxford-uuid:a40b78a2-cf52-48ee-a9d2-11cf1b5636fb2023-03-16T11:53:13ZImpact of hospital antibiotic use on patient-level risk of death among 36,124,372 acute and medical admissions in EnglandJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a40b78a2-cf52-48ee-a9d2-11cf1b5636fbEnglishSymplectic ElementsElsevier2021Budgell, EDavies, TDonker, THopkins, SWyllie, DPeto, TGill, MLlewelyn, MWalker, AS<p><strong>Objectives:</strong> Initiatives to curb hospital antibiotic use might be associated with harm from undertreatment. We examined the extent to which variation in hospital antibiotic prescribing is associated with mortality risk in acute/general medicine inpatients.</p> <p><strong>Methods:</strong> This ecological analysis examined Hospital Episode Statistics from 36,124,372 acute/general medicine admissions (≥16y) to 135 acute hospitals in England, 01/April/2010–31/March/2017. Random-effects meta-regression was used to investigate whether heterogeneity in adjusted 30-day mortality was associated with hospital-level antibiotic use, measured in defined-daily-doses (DDD)/1,000 bed-days. Models also considered DDDs/1,000 admissions and DDDs for narrow-spectrum/broad-spectrum antibiotics, parenteral/oral, and local interpretations of World Health Organization Access, Watch, and Reserve antibiotics.</p> <p><strong>Results:</strong> Hospital-level antibiotic DDDs/1,000 beddays varied 15-fold with comparable variation in broad-spectrum, parenteral, and Reserve antibiotic use. After extensive adjusting for hospital case-mix, the probability of 30-day mortality changed -0.010% (95% CI: -0.064,+0.044) for each increase of 500 hospital-level antibiotic DDDs/1,000 bed-days. Analyses of other metrics of antibiotic use showed no consistent association with mortality risk.</p> <p><strong>Conclusions:</strong> We found no evidence that wide variation in hospital antibiotic use is associated with adjusted mortality risk in acute/general medicine inpatients. Using low-prescribing hospitals as benchmarks could help drive safe and substantial reductions in antibiotic consumption of up-to one-third in this population.</p>
spellingShingle Budgell, E
Davies, T
Donker, T
Hopkins, S
Wyllie, D
Peto, T
Gill, M
Llewelyn, M
Walker, AS
Impact of hospital antibiotic use on patient-level risk of death among 36,124,372 acute and medical admissions in England
title Impact of hospital antibiotic use on patient-level risk of death among 36,124,372 acute and medical admissions in England
title_full Impact of hospital antibiotic use on patient-level risk of death among 36,124,372 acute and medical admissions in England
title_fullStr Impact of hospital antibiotic use on patient-level risk of death among 36,124,372 acute and medical admissions in England
title_full_unstemmed Impact of hospital antibiotic use on patient-level risk of death among 36,124,372 acute and medical admissions in England
title_short Impact of hospital antibiotic use on patient-level risk of death among 36,124,372 acute and medical admissions in England
title_sort impact of hospital antibiotic use on patient level risk of death among 36 124 372 acute and medical admissions in england
work_keys_str_mv AT budgelle impactofhospitalantibioticuseonpatientlevelriskofdeathamong36124372acuteandmedicaladmissionsinengland
AT daviest impactofhospitalantibioticuseonpatientlevelriskofdeathamong36124372acuteandmedicaladmissionsinengland
AT donkert impactofhospitalantibioticuseonpatientlevelriskofdeathamong36124372acuteandmedicaladmissionsinengland
AT hopkinss impactofhospitalantibioticuseonpatientlevelriskofdeathamong36124372acuteandmedicaladmissionsinengland
AT wyllied impactofhospitalantibioticuseonpatientlevelriskofdeathamong36124372acuteandmedicaladmissionsinengland
AT petot impactofhospitalantibioticuseonpatientlevelriskofdeathamong36124372acuteandmedicaladmissionsinengland
AT gillm impactofhospitalantibioticuseonpatientlevelriskofdeathamong36124372acuteandmedicaladmissionsinengland
AT llewelynm impactofhospitalantibioticuseonpatientlevelriskofdeathamong36124372acuteandmedicaladmissionsinengland
AT walkeras impactofhospitalantibioticuseonpatientlevelriskofdeathamong36124372acuteandmedicaladmissionsinengland